-
1
-
-
0020414734
-
Colorectal carcinoma: Evaluation of histologic grade and factors influencing prognosis
-
Chung C.K., Zaino R.J., Stryker J.A.: Colorectal carcinoma: evaluation of histologic grade and factors influencing prognosis. J. Surg. Oncol. 21: 143-148, 1982.
-
(1982)
J. Surg. Oncol.
, vol.21
, pp. 143-148
-
-
Chung, C.K.1
Zaino, R.J.2
Stryker, J.A.3
-
2
-
-
6344245763
-
Clinicopathological characteristics of poorly differentiated adenocarcinoma of the colon and rectum
-
Takeuchi K., Kuwano H., Tsuzuki Y., et al.: Clinicopathological characteristics of poorly differentiated adenocarcinoma of the colon and rectum. Hepatogastroenterology. 51: 1698-1702, 2004.
-
(2004)
Hepatogastroenterology
, vol.51
, pp. 1698-1702
-
-
Takeuchi, K.1
Kuwano, H.2
Tsuzuki, Y.3
-
3
-
-
3042843893
-
Primary signet-ring cell carcinoma of the colorectum
-
Bittorf B., Merkel S., Matzel K.E., Wein A., Dimmler A., Hohenberger W.: Primary signet-ring cell carcinoma of the colorectum. Langenbecks Arch. Surg. 389: 178-183, 2004.
-
(2004)
Langenbecks Arch. Surg.
, vol.389
, pp. 178-183
-
-
Bittorf, B.1
Merkel, S.2
Matzel, K.E.3
Wein, A.4
Dimmler, A.5
Hohenberger, W.6
-
4
-
-
0032942805
-
Molecular characteristics of poorly differentiated adenocarcinoma and signet-ring-cell carcinoma of colorectum
-
Kawabata Y., Tomita N., Monden T., et al.: Molecular characteristics of poorly differentiated adenocarcinoma and signet-ring-cell carcinoma of colorectum. Int. J. Cancer. 84: 33-38, 1999.
-
(1999)
Int. J. Cancer
, vol.84
, pp. 33-38
-
-
Kawabata, Y.1
Tomita, N.2
Monden, T.3
-
5
-
-
0037145728
-
Poorly differentiated adenocarcinoma and mucinous carcinoma of the colon and rectum show higher rates of loss of heterozygosity and loss of E-cadherin expression due to methylation of promoter region
-
Kanazawa T., Watanabe T., Kazama S., Tada T., Koketsu S., Nagawa H.: Poorly differentiated adenocarcinoma and mucinous carcinoma of the colon and rectum show higher rates of loss of heterozygosity and loss of E-cadherin expression due to methylation of promoter region. Int. J. Cancer. 102: 225-229, 2002.
-
(2002)
Int. J. Cancer.
, vol.102
, pp. 225-229
-
-
Kanazawa, T.1
Watanabe, T.2
Kazama, S.3
Tada, T.4
Koketsu, S.5
Nagawa, H.6
-
6
-
-
0023514826
-
Transforming growth factor beta regulation of cell proliferation
-
Moses H.L., Coffey R.J. Jr, Leof E.B., Lyons R.M., Keski-Oja J.: Transforming growth factor beta regulation of cell proliferation. J. Cell. Physiol.; Suppl 5: 1-7, 1987.
-
(1987)
J. Cell. Physiol.
, Issue.SUPPL. 5
, pp. 1-7
-
-
Moses, H.L.1
Coffey Jr., R.J.2
Leof, E.B.3
Lyons, R.M.4
Keski-Oja, J.5
-
7
-
-
0023115518
-
Effects of growth factors on an intestinal epithelial cell line: Transforming growth factor beta inhibits proliferation and stimulates differentiation
-
Kurokowa M., Lynch K., Podolsky D.K.: Effects of growth factors on an intestinal epithelial cell line: transforming growth factor beta inhibits proliferation and stimulates differentiation. Biochem. Biophys Res. Commun. 142: 775-782, 1987.
-
(1987)
Biochem. Biophys Res. Commun.
, vol.142
, pp. 775-782
-
-
Kurokowa, M.1
Lynch, K.2
Podolsky, D.K.3
-
9
-
-
0030849060
-
Mutation analysis of the transforming growth factor-beta type II receptor in human cell lines resistant to growth inhibition by transforming growth factor-beta
-
Vincent F., Nagashima M., Takenoshita S. et al.: Mutation analysis of the transforming growth factor-beta type II receptor in human cell lines resistant to growth inhibition by transforming growth factor-beta. Oncogene. 15: 117-122, 1997.
-
(1997)
Oncogene
, vol.15
, pp. 117-122
-
-
Vincent, F.1
Nagashima, M.2
Takenoshita, S.3
-
10
-
-
0029069131
-
Colon cancer cells that are not growth inhibited by TGF-beta lack functional type I and type II TGF-beta receptors
-
MacKay S.L., Yaswen L.R., Tarnuzzer R.W. et al.: Colon cancer cells that are not growth inhibited by TGF-beta lack functional type I and type II TGF-beta receptors. Ann. Surg. 221: 767-776, 1995.
-
(1995)
Ann. Surg.
, vol.221
, pp. 767-776
-
-
MacKay, S.L.1
Yaswen, L.R.2
Tarnuzzer, R.W.3
-
11
-
-
0030593038
-
DPC4, a candidate tumor suppressor gene at human chromosome 18q21.1
-
Hahn S.A., Schutte M., Hoque A.T., et al.: DPC4, a candidate tumor suppressor gene at human chromosome 18q21.1. Science. 271: 350-353, 1996.
-
(1996)
Science
, vol.271
, pp. 350-353
-
-
Hahn, S.A.1
Schutte, M.2
Hoque, A.T.3
-
12
-
-
0032524069
-
Mutations in the SMAD4/DPC4 gene in juvenile polyposis
-
Howe J.R., Roth S., Ringold J.C. et al.: Mutations in the SMAD4/DPC4 gene in juvenile polyposis. Science. 1998; 280: 1086-1088.
-
(1998)
Science
, vol.280
, pp. 1086-1088
-
-
Howe, J.R.1
Roth, S.2
Ringold, J.C.3
-
14
-
-
0242490137
-
Restoration of SMAD4 by gene therapy reverses the invasive phenotype in pancreatic adenocarcinoma cells
-
Duda D.G., Sunamura M., Lefter et al.: Restoration of SMAD4 by gene therapy reverses the invasive phenotype in pancreatic adenocarcinoma cells. Oncogene. 22: 6857-6864, 2003.
-
(2003)
Oncogene
, vol.22
, pp. 6857-6864
-
-
Duda, D.G.1
Sunamura, M.2
Lefter3
-
15
-
-
0033814963
-
Loss of Dpc4 expression in colonic adenocarcinomas correlates with the presence of metastatic disease
-
Maitra A., Molberg K., Albores-Saavedra J., Lindberg G.: Loss of Dpc4 expression in colonic adenocarcinomas correlates with the presence of metastatic disease. Am. J. Pathol. 157: 1105-1111, 2000.
-
(2000)
Am. J. Pathol.
, vol.157
, pp. 1105-1111
-
-
Maitra, A.1
Molberg, K.2
Albores-Saavedra, J.3
Lindberg, G.4
-
16
-
-
0034032009
-
Loss of expression of Dpc4 in pancreatic intraepithelial neoplasia: Evidence that DPC4 inactivation occurs late in neoplastic progression
-
Wilentz R.E., Iacobuzio-Donahue C.A., Argani P., et al.: Loss of expression of Dpc4 in pancreatic intraepithelial neoplasia: evidence that DPC4 inactivation occurs late in neoplastic progression. Cancer Res. 60: 2002-2006, 2000.
-
(2000)
Cancer Res.
, vol.60
, pp. 2002-2006
-
-
Wilentz, R.E.1
Iacobuzio-Donahue, C.A.2
Argani, P.3
-
17
-
-
0035124190
-
Preserved Smad4 expression in the transforming growth factor beta signaling pathway is a favorable prognostic factor in patients with advanced gastric cancer
-
Xiangming C., Natsugoe S., Takao S. et al.: Preserved Smad4 expression in the transforming growth factor beta signaling pathway is a favorable prognostic factor in patients with advanced gastric cancer. Clin. Cancer Res. 7: 277-282, 2001.
-
(2001)
Clin. Cancer Res.
, vol.7
, pp. 277-282
-
-
Xiangming, C.1
Natsugoe, S.2
Takao, S.3
-
18
-
-
0035671396
-
The SMAD4 protein and prognosis of pancreatic ductal adenocarcinoma
-
Tascilar M., Skinner H.G., Rosty C. et al.: The SMAD4 protein and prognosis of pancreatic ductal adenocarcinoma. Clin. Cancer Res. 7: 4115-4121, 2001.
-
(2001)
Clin. Cancer Res.
, vol.7
, pp. 4115-4121
-
-
Tascilar, M.1
Skinner, H.G.2
Rosty, C.3
-
19
-
-
20244365185
-
SMAD4 as a prognostic marker in colorectal cancer
-
Alazzouzi H., Alhopuro P., Salovaara R. et al.: SMAD4 as a prognostic marker in colorectal cancer. Clin. Cancer Res. 11: 2606-2611, 2005.
-
(2005)
Clin. Cancer Res.
, vol.11
, pp. 2606-2611
-
-
Alazzouzi, H.1
Alhopuro, P.2
Salovaara, R.3
-
20
-
-
0036894028
-
DPC4/Smad4 expression and outcome in pancreatic ductal adenocarcinoma
-
Biankin A.V., Morey A.L., Lee C.S. et al.: DPC4/Smad4 expression and outcome in pancreatic ductal adenocarcinoma. J. Clin. Oncol. 20: 4531-4542, 2002.
-
(2002)
J. Clin. Oncol.
, vol.20
, pp. 4531-4542
-
-
Biankin, A.V.1
Morey, A.L.2
Lee, C.S.3
-
22
-
-
0042666923
-
JTE-522, a cyclooxygenase-2 inhibitor, is an effective chemopreventive agent against rat experimental liver fibrosis
-
Yamamoto H., Kondo M., Nakamori S. et al.: JTE-522, a cyclooxygenase-2 inhibitor, is an effective chemopreventive agent against rat experimental liver fibrosis. Gastroenterology. 125: 556-571, 2003.
-
(2003)
Gastroenterology
, vol.125
, pp. 556-571
-
-
Yamamoto, H.1
Kondo, M.2
Nakamori, S.3
-
23
-
-
0036293981
-
Frequent loss of SMAD4/DPC4 protein in colorectal cancers
-
Salovaara R., Roth S., Loukola A. et al. Frequent loss of SMAD4/DPC4 protein in colorectal cancers. Gut. 51: 56-59, 2002.
-
(2002)
Gut
, vol.51
, pp. 56-59
-
-
Salovaara, R.1
Roth, S.2
Loukola, A.3
-
24
-
-
0033891752
-
Immunohistochemical labeling for dpc4 mirrors genetic status in pancreatic adenocarcinomas: A new marker of DPC4 inactivation
-
Wilentz R.E., Su G.H., Dai J.L., et al. Immunohistochemical labeling for dpc4 mirrors genetic status in pancreatic adenocarcinomas: a new marker of DPC4 inactivation. Am. J. Pathol. 156: 37-43, 2000.
-
(2000)
Am. J. Pathol.
, vol.156
, pp. 37-43
-
-
Wilentz, R.E.1
Su, G.H.2
Dai, J.L.3
-
25
-
-
10344227149
-
Mutations of the transforming growth factor beta type II receptor gene and microsatellite instability in gastric cancer
-
Ohue M., Tomita N., Monden T. et al.: Mutations of the transforming growth factor beta type II receptor gene and microsatellite instability in gastric cancer. Int. J. Cancer. 68: 203-206, 1996.
-
(1996)
Int. J. Cancer.
, vol.68
, pp. 203-206
-
-
Ohue, M.1
Tomita, N.2
Monden, T.3
-
26
-
-
0033587156
-
Higher frequency of Smad4 gene mutation in human colorectal cancer with distant metastasis
-
Miyaki M., Iijima T., Konishi M. et al.: Higher frequency of Smad4 gene mutation in human colorectal cancer with distant metastasis. Oncogene. 18: 3098-3103, 1999.
-
(1999)
Oncogene
, vol.18
, pp. 3098-3103
-
-
Miyaki, M.1
Iijima, T.2
Konishi, M.3
-
27
-
-
0348227997
-
Loss of DPC4 expression and its correlation with clinicopathological parameters in pancreatic carcinoma
-
Hua Z., Zhang Y.C., Hu X.M., Jia Z.G.: Loss of DPC4 expression and its correlation with clinicopathological parameters in pancreatic carcinoma. World J. Gastroenterol. 9: 2764-2767, 2003.
-
(2003)
World J. Gastroenterol.
, vol.9
, pp. 2764-2767
-
-
Hua, Z.1
Zhang, Y.C.2
Hu, X.M.3
Jia, Z.G.4
-
28
-
-
0033572255
-
Gastric and duodenal polyps in Smad4 (Dpc4) knockout mice
-
Takaku K., Miyoshi H., Matsunaga A., Oshima M., Sasaki N., Taketo M.M.: Gastric and duodenal polyps in Smad4 (Dpc4) knockout mice. Cancer Res. 59: 6113-6117, 1999.
-
(1999)
Cancer Res.
, vol.59
, pp. 6113-6117
-
-
Takaku, K.1
Miyoshi, H.2
Matsunaga, A.3
Oshima, M.4
Sasaki, N.5
Taketo, M.M.6
-
29
-
-
0032489508
-
Intestinal tumorigenesis in compound mutant mice of both Dpc4 (Smad4) and Ape genes
-
Takaku K., Oshima M., Miyoshi H., Matsui M., Seldin M.F., Taketo M.M.: Intestinal tumorigenesis in compound mutant mice of both Dpc4 (Smad4) and Ape genes. Cell. 92: 645-656, 1998.
-
(1998)
Cell
, vol.92
, pp. 645-656
-
-
Takaku, K.1
Oshima, M.2
Miyoshi, H.3
Matsui, M.4
Seldin, M.F.5
Taketo, M.M.6
-
30
-
-
0035859859
-
SMAD4 mutations in colorectal cancer probably occur before chromosomal instability, but after divergence of the microsatellite instability pathway
-
Woodford-Richens K.L., Rowan A.J., Gorman P. et al.: SMAD4 mutations in colorectal cancer probably occur before chromosomal instability, but after divergence of the microsatellite instability pathway. Proc. Natl. Acad. Sci. USA. 98: 9719-9723, 2001.
-
(2001)
Proc. Natl. Acad. Sci. USA
, vol.98
, pp. 9719-9723
-
-
Woodford-Richens, K.L.1
Rowan, A.J.2
Gorman, P.3
-
31
-
-
0029808666
-
Somatic alterations of the DPC4 gene in human colorectal cancers in vivo
-
Takagi Y., Kohmura H., Futamura M. et al.: Somatic alterations of the DPC4 gene in human colorectal cancers in vivo. Gastroenterology. 111: 1369-1372, 1996.
-
(1996)
Gastroenterology
, vol.111
, pp. 1369-1372
-
-
Takagi, Y.1
Kohmura, H.2
Futamura, M.3
-
32
-
-
0033774806
-
No SMAD4 hypermethylation in colorectal cancer
-
Roth S., Laiho P., Salovaara R., Launonen V., Aaltonen L.A.: No SMAD4 hypermethylation in colorectal cancer. Br. J. Cancer. 83: 1015-1019, 2000.
-
(2000)
Br. J. Cancer
, vol.83
, pp. 1015-1019
-
-
Roth, S.1
Laiho, P.2
Salovaara, R.3
Launonen, V.4
Aaltonen, L.A.5
-
33
-
-
1842479071
-
Defective expression of transforming growth factor beta receptor type II is associated with CpG methylated promoter in primary non-small cell lung cancer
-
Zhang H.T., Chen X.F., Wang M.H. et al.: Defective expression of transforming growth factor beta receptor type II is associated with CpG methylated promoter in primary non-small cell lung cancer. Clin. Cancer Res. 10: 2359-2367, 2004.
-
(2004)
Clin. Cancer Res.
, vol.10
, pp. 2359-2367
-
-
Zhang, H.T.1
Chen, X.F.2
Wang, M.H.3
-
34
-
-
0036875138
-
Altered expression of the receptor and ligand in the TGF-beta signaling pathway in diffusely infiltrating colon carcinoma
-
Nagayama S., Onodera H., Toguchida J., Imamura M.: Altered expression of the receptor and ligand in the TGF-beta signaling pathway in diffusely infiltrating colon carcinoma. Anticancer Res. 22: 3545-3554, 2002.
-
(2002)
Anticancer Res.
, vol.22
, pp. 3545-3554
-
-
Nagayama, S.1
Onodera, H.2
Toguchida, J.3
Imamura, M.4
|